Fertility supplements cannot reliably increase AMH levels or restore the number of eggs in the ovaries. Some supplements may support general reproductive health or correct nutrient deficiencies, but there is limited evidence that they improve pregnancy or live birth rates in women with low AMH. The benefits, appropriate doses, and safety of these products depend on the ingredients and a person's health needs.
How Does AMH Relate to Fertility?
Anti-Müllerian hormone (AMH) is produced by cells surrounding small, developing follicles in the ovaries. A blood test measures AMH to help estimate ovarian reserve, which refers to the number of eggs remaining in the ovaries.
AMH levels generally decrease with age. However, a low AMH result does not automatically mean that pregnancy is impossible. Likewise, a higher AMH level does not guarantee that someone will conceive.
According to the American Society for Reproductive Medicine (ASRM), AMH is useful for estimating how the ovaries may respond to stimulation during fertility treatment. However, ovarian reserve tests are poor predictors of reproductive potential independently of age.
This distinction matters when evaluating fertility supplements. Even if a product appears to change AMH measurements, that does not establish that it improves egg quality, increases the chances of natural pregnancy, or leads to more live births.
Can Supplements Increase Low AMH Levels?
There is currently no supplement proven to consistently raise AMH levels and improve fertility outcomes. Several products are marketed for ovarian reserve, but the evidence varies considerably between ingredients.
Some studies have investigated whether antioxidants, hormones, and nutritional supplements affect ovarian function. However, changes in laboratory measurements are not the same as improvements in pregnancy outcomes.
It is also important to distinguish between two different goals:
- Supporting reproductive health: Correcting a nutritional deficiency or meeting nutritional needs before pregnancy may benefit overall health.
- Increasing ovarian reserve: Supplements have not been shown to replace lost eggs or reliably reverse the age-related decline in ovarian reserve.
A fertility specialist can help interpret AMH alongside age, menstrual history, ultrasound findings, and other relevant fertility information rather than relying on AMH alone.
Which Fertility Supplements Are Commonly Used for Low AMH?
Coenzyme Q10 (CoQ10)
Coenzyme Q10 is a substance naturally found in the body that helps cells produce energy. It also has antioxidant properties. These functions have made it a subject of research into reproductive health and ovarian function.
CoQ10 is sometimes used by women preparing for fertility treatment, particularly those concerned about diminished ovarian reserve or their response to ovarian stimulation.
Although some fertility studies have reported promising intermediate outcomes, the available evidence does not establish that CoQ10 reliably increases AMH or improves live birth rates. Research findings should not be interpreted as proof that it restores ovarian reserve.
The National Center for Complementary and Integrative Health (NCCIH) reports that CoQ10 can cause digestive upset or insomnia and may interact with medications such as warfarin and insulin.
Dosage: There is no established, evidence-based CoQ10 dose specifically for increasing AMH. Fertility research has used different amounts and treatment schedules, so a dose should not be selected solely because it appears in a supplement advertisement.
Anyone considering CoQ10 during fertility treatment should discuss the intended dose, other medications, and whether to continue it after pregnancy is confirmed with their healthcare professional.
Dehydroepiandrosterone (DHEA)
DHEA is a hormone produced naturally by the body. It is involved in the production of other hormones, including estrogen and testosterone.
Some fertility clinics have studied DHEA supplementation in women with a reduced response to ovarian stimulation. However, research has not established a consistent improvement in meaningful fertility outcomes.
The European Society of Human Reproduction and Embryology (ESHRE), in its updated ovarian stimulation guideline, recommends against using DHEA before or during ovarian stimulation in both low and normal responders undergoing IVF or ICSI.
Dosage: DHEA should not be self-prescribed for low AMH. There is no recommended routine dose for raising AMH or improving fertility, and taking larger amounts does not establish greater benefit.
Because DHEA affects hormone levels, possible adverse effects include acne, unwanted hair growth, and other androgen-related changes. Its hormonal activity also makes medical supervision particularly important for people with hormone-sensitive conditions or those who could become pregnant.
Vitamin D
Vitamin D helps the body absorb calcium and supports several normal biological functions. Researchers have also examined possible relationships between vitamin D levels, AMH, and reproductive health.
However, an association between vitamin D status and an AMH measurement does not prove that vitamin D supplementation increases ovarian reserve.
For someone with vitamin D deficiency, supplementation may be appropriate to correct the deficiency. That is a different goal from using high-dose vitamin D specifically to increase AMH.
Dosage: Vitamin D intake should reflect age, dietary intake, medical history, and any identified deficiency. Adults generally need 600 IU (15 mcg) daily through age 70, including during pregnancy. Higher treatment doses may be appropriate for certain deficiencies under medical guidance.
Excessive vitamin D intake can raise calcium levels in the blood and cause harmful effects. Taking large doses without a medical reason is not a proven fertility strategy.
Myo-Inositol
Myo-inositol is a naturally occurring substance involved in cellular signaling. It is commonly marketed for reproductive health, especially for people with polycystic ovary syndrome (PCOS).
PCOS can be associated with higher AMH levels because of an increased number of small ovarian follicles. However, PCOS-related concerns and diminished ovarian reserve are different clinical situations.
The 2023 International Evidence-Based PCOS Guideline, published through ASRM, states that inositol should be considered experimental as a fertility treatment for women with PCOS and infertility because its benefits and risks remain uncertain.
Dosage: No specific type, dose, or combination of inositol is recommended for fertility treatment on the basis of current evidence. It is not an established treatment for increasing low AMH.
Folic Acid and Prenatal Vitamins
Folic acid differs from supplements marketed to improve ovarian reserve. Its well-established role is helping prevent neural tube defects, which are serious birth defects affecting the developing brain and spine.
According to the Centers for Disease Control and Prevention (CDC), women capable of becoming pregnant should get 400 micrograms (mcg) of folic acid each day.
Dosage: The general recommendation is 400 mcg daily. People with certain medical histories, including a previous pregnancy affected by a neural tube defect, may require a different dose prescribed by a healthcare professional.
Folic acid is important when preparing for pregnancy, but it is not a treatment for low AMH. Prenatal vitamins may also provide other nutrients needed during pregnancy, although their formulations vary.
Fertility Supplements: Benefits and Dosage at a Glance
| Supplement | Potential benefit | Dosage guidance | Evidence for raising AMH |
|---|---|---|---|
| CoQ10 | Supports normal cellular energy processes; being studied in fertility care | No established AMH-specific dose | Not reliably proven |
| DHEA | Investigated for ovarian response in IVF | Not recommended for routine use in ovarian stimulation | No established clinical benefit |
| Vitamin D | Corrects deficiency and supports bone and general health | Generally 600 IU daily for adults through age 70; deficiency treatment varies | Insufficient evidence of a reliable benefit |
| Myo-inositol | May improve some metabolic measures in PCOS | No recommended fertility-treatment dose | Not established |
| Folic acid | Helps prevent neural tube defects | 400 mcg daily for most women capable of pregnancy | Not an AMH-raising treatment |
The dosage information above is general educational guidance, not a personalized supplement plan. In particular, amounts used in research studies should not be treated as proven or recommended doses for improving AMH.
Are Fertility Supplements Safe to Take Together?
Taking several fertility supplements together is not necessarily more effective than taking one. Combination products may contain overlapping ingredients, creating a risk of unintentionally consuming excessive amounts.
Safety concerns may include:
- Medication interactions: Some supplements can interfere with prescription medicines or affect their action.
- Excessive nutrient intake: Combining a prenatal vitamin with additional vitamin or mineral products may lead to unnecessarily high doses.
- Hormonal effects: Products containing DHEA can alter hormone exposure and may be unsuitable for some people.
- Uncertain pregnancy safety: Not every fertility supplement has been adequately studied during pregnancy.
- Product quality: Ingredient amounts, combinations, and manufacturing quality can differ between supplement brands.
Before combining products, review their ingredient labels with a pharmacist, gynecologist, or fertility specialist. This is particularly important when taking prescription medicines, undergoing fertility treatment, or preparing for pregnancy.
Does a Higher AMH Level After Supplements Mean Better Fertility?
Not necessarily. A change in AMH after starting a supplement does not prove that the supplement caused the change or improved the chance of pregnancy.
AMH results can be influenced by factors such as laboratory testing methods and hormonal contraception. Clinicians interpret results in the context of age, medical history, and other fertility findings.
AMH also measures a different aspect of reproductive health from egg quality. A higher result does not establish that eggs are healthier or that pregnancy will occur sooner.
For individuals undergoing IVF, AMH can help anticipate the number of eggs that may be retrieved after ovarian stimulation. However, it is less useful for predicting whether those eggs will result in a successful pregnancy.
Should Supplements Be Taken for Three Months Before Fertility Treatment?
Some fertility supplement plans are promoted as three-month programs. However, there is no universally established supplement course that has been shown to restore ovarian reserve or reliably improve live birth rates.
Research protocols differ in their treatment duration, ingredients, doses, and outcomes. For this reason, a treatment period used in one study should not automatically become a recommendation for every patient.
Anyone preparing for IVF or another fertility procedure should discuss supplements with the treating clinic before starting them. The clinic can explain whether a particular product has a reasonable role in the treatment plan and whether any supplements should be stopped.
It is especially important not to postpone a recommended fertility evaluation or treatment simply to complete an unproven supplement course.
What Helps When AMH Is Low?
When AMH is low, the most useful next step is understanding what the result means in the person's specific circumstances.
Fertility assessment may include a discussion of reproductive goals, menstrual patterns, previous pregnancies, medical history, and any difficulties conceiving. Depending on the situation, clinicians may consider an antral follicle count by ultrasound or other fertility tests.
Age is particularly important. Ovarian reserve and reproductive potential change over time, and an AMH result should not replace age-based fertility counseling.
General steps that support reproductive health include eating a balanced diet, avoiding smoking, addressing relevant nutritional deficiencies, and taking recommended folic acid when pregnancy is possible.
These measures support overall health but should not be presented as proven methods for rebuilding ovarian reserve.
When Should You Speak With a Fertility Specialist?
It may be helpful to arrange a consultation if an AMH result is concerning, fertility treatment is being considered, or pregnancy has not occurred after a period of trying.
For people younger than 35, fertility evaluation is generally recommended after 12 months of regular unprotected intercourse without pregnancy. For those aged 35 or older, evaluation is commonly recommended after six months. People older than 40, or those with known fertility concerns, may benefit from more immediate assessment.
A consultation can also be useful before starting supplements marketed for diminished ovarian reserve, especially products containing hormones or multiple active ingredients.
The key takeaway: Fertility supplements may have a role in correcting deficiencies or supporting specific health needs, but none is proven to reliably restore ovarian reserve. Decisions about supplements are best based on the evidence for actual fertility outcomes, not only promises of higher AMH numbers.